BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/06/1994

Opportunity For Licensing: Neutralizing Monoclonal Antibodies for Respiratory Syncytial Virus

The National Institutes of Health (NIH) is seeking a licensee to develop human monoclonal antibodies against respiratory syncytial virus (RSV) through preclinical, clinical, and commercial stages.

Source: Federal Register — Health and Human ServicesOpen original release →